- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03955497
Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury
Efficacy and Safety Research of Autologous Adipose-derived Mesenchymal Stem Cell Gel in the Treatment of Cartilage Damage in the Knee
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
- Name: Songlin Li, MD
- Phone Number: 0531-82166541
- Email: bysonglin@126.com
Study Contact Backup
- Name: Heran Ma, Ph.D
- Phone Number: +86 17364590020
- Email: 2523129824@qq.com
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Qilu Hospital of Shandong University
-
Contact:
- Heran Ma, Ph.D
- Phone Number: +8617364590020
- Email: 2523129824@qq.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18-65 years, male and female, patient can tolerate surgery;
- Clinical diagnosis of degenerative arthritis by Radiographic Criteria;
- Obviously extra-articular malformation;
- Good contralateral interventricular cartilage;
- Course of disease ≥ six months;
- There was no obvious abnormality in tumor marker detection,or patient was evaluated has not at the risk of cancer;
- Subjects who understand and sign the consent form for this study.
Exclusion Criteria:
- Acute joint injury;
- Patients with severe primary diseases, such as cardiovascular,cerebrovascular, liver, kidney and hematopoietic system, and psychosis;
- Cancer patients;
- Women who are pregnant or breast feeding,or allergic constitution patient;
- Positive serology for HIV-1 or HIV-2, Hepatitis B (HBsAg, Anti-Hepatitis C virus -Ab), Hepatitis C (Anti-hepatitis C virus -Ab) and syphilis;
- Receive other open surgery related to knee operation within 6 months;
- Participation in another clinical trial;
- Failing to comply with the inclusion criteria, unwilling to comply with the research approach, or incomplete data affecting the curative effect or safety judgment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Autologous Adipose-derived Mesenchymal Stem Cell Gel
The experimental group received intra-articular injection of Autologous Adipose-derived Mesenchymal Stem Cell Gel one month after operation.
|
The experimental group received intra-articular injection of Autologous Adipose-derived Mesenchymal Stem Cell Gel one month after operation.
In the experimental group, abdominal fat was extracted before operation to prepare Autologous Adipose-derived Mesenchymal Stem Cell Gel.
Other Names:
|
Placebo Comparator: sodium hyaluronate
The control group received intra-articular injection of sodium hyaluronate one month after operation.
|
The control group received intra-articular injection of sodium hyaluronate one month after operation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital for special surgery knee score postoperative 1 month
Time Frame: postoperative 1 month
|
Hospital for special surgery knee score is a knee function scoring system with a full score of 100.
0 means the loss of knee function, 100 means the best knee function, and the greater the value, the better knee function.
|
postoperative 1 month
|
Hospital for special surgery knee score postoperative 3 month
Time Frame: postoperative 3 month
|
Hospital for special surgery knee score is a knee function scoring system with a full score of 100.
0 means the loss of knee function, 100 means the best knee function, and the greater the value, the better knee function.
|
postoperative 3 month
|
Hospital for special surgery knee score postoperative 6 month
Time Frame: postoperative 6 month
|
Hospital for special surgery knee score is a knee function scoring system with a full score of 100.
0 means the loss of knee function, 100 means the best knee function, and the greater the value, the better knee function.
|
postoperative 6 month
|
Hospital for special surgery knee score postoperative 12 month
Time Frame: postoperative 12 month
|
Hospital for special surgery knee score is a knee function scoring system with a full score of 100.
0 means the loss of knee function, 100 means the best knee function, and the greater the value, the better knee function.
|
postoperative 12 month
|
Hospital for special surgery knee score postoperative 24 month
Time Frame: postoperative 24 month
|
Hospital for special surgery knee score is a knee function scoring system with a full score of 100.
0 means the loss of knee function, 100 means the best knee function, and the greater the value, the better knee function.
|
postoperative 24 month
|
Hospital for special surgery knee score postoperative 36 month
Time Frame: postoperative 36 month
|
Hospital for special surgery knee score is a knee function scoring system with a full score of 100.
0 means the loss of knee function, 100 means the best knee function, and the greater the value, the better knee function.
|
postoperative 36 month
|
Visual Analogue Scale Postoperative Day 1
Time Frame: Postoperative Day 1
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative Day 1
|
Visual Analogue Scale Postoperative Day 2
Time Frame: Postoperative Day 2
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative Day 2
|
Visual Analogue Scale Postoperative Day 3
Time Frame: Postoperative Day 3
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative Day 3
|
Visual Analogue Scale Postoperative Day 7
Time Frame: Postoperative Day 7
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative Day 7
|
Visual Analogue Scale Postoperative 1 month
Time Frame: Postoperative 1 month
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative 1 month
|
Visual Analogue Scale Postoperative 3 month
Time Frame: Postoperative 3 month
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative 3 month
|
Visual Analogue Scale Postoperative 6 month
Time Frame: Postoperative 6 month
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative 6 month
|
Visual Analogue Scale Postoperative 12 month
Time Frame: Postoperative 12 month
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative 12 month
|
Visual Analogue Scale Postoperative Day One
Time Frame: Postoperative Day One
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative Day One
|
Visual Analogue Scale Postoperative 24 month
Time Frame: Postoperative 24month
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative 24month
|
Visual Analogue Scale Postoperative 36 month
Time Frame: Postoperative 36 month
|
Draw a 10 cm horizontal line on the paper.
One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain.
The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
|
Postoperative 36 month
|
Evaluation of cartilage repair under MRI postoperative 12 month
Time Frame: Postoperative 12 month
|
Recht criterion was used for grading articular cartilage injury of knee joint, including 0-IV grade, in which: 0 grade, normal articular cartilage, no obvious abnormal signal was found; 1 grade, the layered structure of cartilage disappeared, and there were focal low signal areas, but the surface was smooth; 2 grade, the surface of cartilage was irregular, the depth of cartilage injury was less than 50% cartilage thickness; 3 grade, the surface of cartilage was heavy.
The degree of injury is irregular, the depth of injury is more than 50% of the thickness of cartilage or through the whole layer, but the surface of cartilage is not completely exfoliated; Grade IV, full-thickness cartilage defect, articular cartilage injury deep to the cortex, subchondral bone exposed.
|
Postoperative 12 month
|
Evaluation of cartilage repair under MRI postoperative 24 month
Time Frame: Postoperative 24 month
|
Recht criterion was used for grading articular cartilage injury of knee joint, including 0-IV grade, in which: 0 grade, normal articular cartilage, no obvious abnormal signal was found; 1 grade, the layered structure of cartilage disappeared, and there were focal low signal areas, but the surface was smooth; 2 grade, the surface of cartilage was irregular, the depth of cartilage injury was less than 50% cartilage thickness; 3 grade, the surface of cartilage was heavy.
The degree of injury is irregular, the depth of injury is more than 50% of the thickness of cartilage or through the whole layer, but the surface of cartilage is not completely exfoliated; Grade IV, full-thickness cartilage defect, articular cartilage injury deep to the cortex, subchondral bone exposed.
|
Postoperative 24 month
|
Evaluation of cartilage repair under MRI postoperative 36 month
Time Frame: Postoperative 36 month
|
Recht criterion was used for grading articular cartilage injury of knee joint, including 0-IV grade, in which: 0 grade, normal articular cartilage, no obvious abnormal signal was found; 1 grade, the layered structure of cartilage disappeared, and there were focal low signal areas, but the surface was smooth; 2 grade, the surface of cartilage was irregular, the depth of cartilage injury was less than 50% cartilage thickness; 3 grade, the surface of cartilage was heavy.
The degree of injury is irregular, the depth of injury is more than 50% of the thickness of cartilage or through the whole layer, but the surface of cartilage is not completely exfoliated; Grade IV, full-thickness cartilage defect, articular cartilage injury deep to the cortex, subchondral bone exposed.
|
Postoperative 36 month
|
Degree of meniscus injury under MRI postoperative 12 month
Time Frame: postoperative 12 month
|
Stoller's criteria were used in the classification of meniscal injuries, including 0-3 grades, in which: 0 grade, the shape of meniscus was regular, complete and even low signal; 1 grade, focal ellipse or circular high signal appeared in the meniscus, which did not extend to the articular surface and margin of the meniscus; 2 grade, the meniscus showed horizontal linear high signal extending to the articular margin of the meniscus. But it did not exceed the articular surface; in grade III, the shape of meniscus was irregular and incomplete. Irregular or linear high signal appeared in the meniscus and extended to the articular surface of meniscus. The grade I and II symptoms of meniscus injury were mild, suggesting meniscus degeneration, and grade III suggesting meniscus tear. |
postoperative 12 month
|
Degree of meniscus injury under MRI postoperative 24 month
Time Frame: postoperative 24 month
|
Stoller's criteria were used in the classification of meniscal injuries, including 0-3 grades, in which: 0 grade, the shape of meniscus was regular, complete and even low signal; 1 grade, focal ellipse or circular high signal appeared in the meniscus, which did not extend to the articular surface and margin of the meniscus; 2 grade, the meniscus showed horizontal linear high signal extending to the articular margin of the meniscus. But it did not exceed the articular surface; in grade III, the shape of meniscus was irregular and incomplete. Irregular or linear high signal appeared in the meniscus and extended to the articular surface of meniscus. The grade I and II symptoms of meniscus injury were mild, suggesting meniscus degeneration, and grade III suggesting meniscus tear. |
postoperative 24 month
|
Degree of meniscus injury under MRI postoperative 36 month
Time Frame: postoperative 36 month
|
Stoller's criteria were used in the classification of meniscal injuries, including 0-3 grades, in which: 0 grade, the shape of meniscus was regular, complete and even low signal; 1 grade, focal ellipse or circular high signal appeared in the meniscus, which did not extend to the articular surface and margin of the meniscus; 2 grade, the meniscus showed horizontal linear high signal extending to the articular margin of the meniscus. But it did not exceed the articular surface; in grade III, the shape of meniscus was irregular and incomplete. Irregular or linear high signal appeared in the meniscus and extended to the articular surface of meniscus. The grade I and II symptoms of meniscus injury were mild, suggesting meniscus degeneration, and grade III suggesting meniscus tear. |
postoperative 36 month
|
Evaluation of cartilage repair under arthroscope postoperative 12 month
Time Frame: postoperative 12 month
|
The arthroscopic classification of knee joint cartilage injury refers to the classification criteria formulated by the International Association of Cartilage Repair, which includes 0-IV grades, of which: 0 grade is normal articular cartilage; 1 grade is the surface injury of cartilage with soft edema on the surface, with only small cracks and intact structure; 2 grade is partial cartilage injury, which extends downward from the surface, but the depth of injury is less than 50% cartilage thickness.
Grade III, deep articular injury, injury depth > 50% cartilage thickness or through the whole layer; Grade IV, deep articular cartilage injury to the bone cortex, full-thickness cartilage defect, subchondral bone exposure.
|
postoperative 12 month
|
Degree of meniscus injury under arthroscope postoperative 12 month
Time Frame: postoperative 12 month
|
The degree of meniscus injury under arthroscopy was classified into three grades, including normal, degenerative and tear.
|
postoperative 12 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Squatting to Standing Time postoperative 1 month
Time Frame: postoperative 1 month
|
The patient squatted on the floor and then stood up completely for five consecutive times, recording the time required.
|
postoperative 1 month
|
Squatting to Standing Time postoperative 3 month
Time Frame: postoperative 3 month
|
The patient squatted on the floor and then stood up completely for five consecutive times, recording the time required.
|
postoperative 3 month
|
Squatting to Standing Time postoperative 6 month
Time Frame: postoperative 6 month
|
The patient squatted on the floor and then stood up completely for five consecutive times, recording the time required.
|
postoperative 6 month
|
Squatting to Standing Time postoperative 12 month
Time Frame: postoperative 12 month
|
The patient squatted on the floor and then stood up completely for five consecutive times, recording the time required.
|
postoperative 12 month
|
Squatting to Standing Time postoperative 24 month
Time Frame: postoperative 24 month
|
The patient squatted on the floor and then stood up completely for five consecutive times, recording the time required.
|
postoperative 24 month
|
Squatting to Standing Time postoperative 36 month
Time Frame: postoperative 36 month
|
The patient squatted on the floor and then stood up completely for five consecutive times, recording the time required.
|
postoperative 36 month
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;2012:812693. doi: 10.1155/2012/812693. Epub 2012 Apr 12.
- Yu D, Xu J, Liu F, Wang X, Mao Y, Zhu Z. Subchondral bone changes and the impacts on joint pain and articular cartilage degeneration in osteoarthritis. Clin Exp Rheumatol. 2016 Sep-Oct;34(5):929-934. Epub 2016 Aug 31.
- Wilusz RE, Sanchez-Adams J, Guilak F. The structure and function of the pericellular matrix of articular cartilage. Matrix Biol. 2014 Oct;39:25-32. doi: 10.1016/j.matbio.2014.08.009. Epub 2014 Aug 27.
- Chareancholvanich K, Pornrattanamaneewong C, Narkbunnam R. Increased cartilage volume after injection of hyaluronic acid in osteoarthritis knee patients who underwent high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc. 2014 Jun;22(6):1415-23. doi: 10.1007/s00167-013-2735-1. Epub 2013 Oct 27.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018023 (OTHER: Sun Yat-sen University 5010 clinical program)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
Clinical Trials on Autologous Adipose-derived Mesenchymal Stem Cell Gel
-
Celal Bayar UniversityThe Scientific and Technological Research Council of Turkey; Acıbadem LabcellCompletedSkin Diseases | Immune System Diseases | Autoimmune Diseases | UrticariaTurkey
-
Inbo HanCHA UniversityUnknownLow Back PainKorea, Republic of
-
Mohamad BydonCompletedParalysis | Spinal Cord InjuriesUnited States
-
The Foundation for Orthopaedics and Regenerative...SuspendedSpinal Cord InjuriesGreece
-
National Yang Ming UniversityCompletedThe Sequelae Caused by Severe Brain InjuryTaiwan
-
The Foundation for Orthopaedics and Regenerative...Suspended
-
Institute of Biophysics and Cell Engineering of...Belarusian State Medical UniversityCompleted
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasCompletedDiabetes | Critical Limb Ischemia (CLI)Spain
-
Mayo ClinicRegenerative Medicine MinnesotaTerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic Kidney Disease | Diabetic Nephropathies | Chronic Kidney Disease | Kidney Failure | Diabetic Nephropathy Type 2 | Kidney InsufficiencyUnited States
-
Anterogen Co., Ltd.TerminatedPerianal Fistula | Primary; ComplexKorea, Republic of